Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis

by Engel Samuel S, Golm Gregory T, Shapiro Deborah, Davies Michael J, Kaufman Keith D, Goldstein Barry J
Published 2013-01-01

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

by Guo Hua, Golm Gregory T, Johnson Jeremy, Round Elizabeth, Engel Samuel S, Williams-Herman Debora, Musser Bret J, Davies Michael J, Kaufman Keith D, Goldstein Barry J
Published 2010-04-01